Purdue Pharma hopes to gain six extra months next year of patent protection for OxyContin by testing whether the powerful painkiller is safe for children.
No comments:
Post a Comment
If you have a comment regarding the post above, please feel free to leave it here.
No comments:
Post a Comment
If you have a comment regarding the post above, please feel free to leave it here.